Meet the speaker: Prof Mark Bullimore

The SILMO Academy by IOA will be taking place 12 April - 14 April in Singapore. Prof Mark Bullimore will be talking about the latest trends in myopia management.

In recent years, effective optical and pharmaceutical therapies have been developed and validated that can slow myopia by meaningful amounts. Likewise, the prevalence of myopia is increasing and its role in uncorrectable visual impairment has become clear—around one third of all uncorrectable visual impairment can be attributed to myopia. High quality evidence continues to emerge from rigorous clinical trials with multiple years of data, good retention of subjects, concurrent controls or placebo, masking (when possible), and objective outcome measures: optical biometry and cycloplegic auto-refraction. Quality of vision is good and safety is satisfactory. Thus, practitioners have a growing portfolio of therapies that allow them to tailor management to a child’s lifestyle and address safety concerns.

Professor Bullimore is an internationally renowned scientist, speaker, and educator based in Boulder, Colorado. He received his Optometry degree and PhD in Vision Science from Aston University in Birmingham, England. He spent most of his career at the Ohio State University and the University of California at Berkeley and is now Adjunct Professor at the University of Houston. He is the former Editor of Optometry and Vision Science. His expertise in myopia, contact lenses, low vision, presbyopia, and refractive surgery means that he is consultant for a number of ophthalmic, surgical, and pharmaceutical companies. This work has resulted in approval of, among others, Paragon CRT, Alcon’s iLux, and CooperVision’s MiSight lens.

Find out more about SILMO Academy by IOA here.